Hypothalamic-pituitary-adrenal axis activity in obese men with and without sleep apnea: Effects of continuous positive airway pressure therapy

Journal of Clinical Endocrinology and Metabolism

Volumn 92, Issue 11, 2007, Pages 4199-4207

  Vgontzas, Alexandros N ^a   Pejovic, S ^a   Zoumakis, E ^b   Lin, H M ^a   Bentley, C M ^a   Bixler, E O ^a   Sarrigiannidis, A ^a   Basta, M ^a   Chrousos, G P ^b  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF ATHENS   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; HYDROCORTISONE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICOTROPIN BLOOD LEVEL; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DISEASE SEVERITY; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYDROCORTISONE RELEASE; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; LABORATORY; MALE; MENTAL STRESS; OBESITY; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SLEEP APNEA SYNDROME;

OVIS;

EID: 35948976927     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2007-0774     Document Type: Article

References (43)

1. Vgontzas AN, Kales A 1999 Sleep and its disorders. Annu Rev Med 50:387-400
2. Buckley TM, Schatzberg AF 2005 On the interactions of the hypothalamicpituitary-adrenal (HPA) axis and sleep: normal HPA axis activity and circadian rhythm, exemplary sleep disorders. J Clin Endocrinol Metab 90:3106-3114
3. Fletcher EC, Miller J, Schaaf JW, Fletcher JG 1987 Urinary catecholamines before and after tracheostomy in patients with obstructive sleep apnea and hypertension. Sleep 10:35-44
4. Waradckar NV, Sinoway LI, Zwillich CW, Leuenberger UA 1996 Influence of treatment on muscle sympathetic nerve activity in sleep apnea. Am J Respir Crit Care Med 153:1333-1338
5. Grunstein RR, Handelsman DJ, Lawrence SJ, Blackwell C, Caterson ID, Sullivan CE 1989 Neuroendocrine dysfunction in sleep apnea: reversal by continuous positive airway pressure therapy. J Clin Endocrinol Metab 68:352-358
6. Grunstein RR, Stewart DA, Lloyd H, Akinci M, Cheng N, Sulivan CE 1996 Acute withdrawal of nasal CPAP in obstructive sleep apnea does not cause a rise in stress hormones. Sleep 19:774-782
7. Bratel T, Wennlund A, Carlstrom K 1999 Pituitary reactivity, androgens and catecholamines in obstructive sleep apnoea. Effects of continuous positive airway pressure treatment (CPAP). Respir Med 93:1-7
8. Meston N, Davies RJO, Mullins R, Jenkinson C, Wass JAH, Stradling JR 2003 Endocrine effects of nasal continuous positive airway pressure in male patients with obstructive sleep apnoea. J Intern Med 254:447-454
9. Vgontzas AN, Papanicolaou DA, Bixler EO, Hopper K, Lotsikas A, Lin HM, Kales A, Chrousos GP 2000 Sleep apnea and daytime sleepiness and fatigue: relation to visceral obesity, insulin resistance, and hypercytokinemia. J Clin Endocrinol Metab 85:1151-1158
10. Vgontzas AN, Bixler EO, Chrousos GP 2005 Sleep apnea is a manifestation of the metabolic syndrome. Sleep Med Rev 9:211-224
11. Chrousos GP 2000 The role of stress and the hypothalamic- pituitary-adrenal axis in the pathogenesis of the metabolic syndrome: neuro-endocrine and target tissue-related causes. Int J Obes 24(Suppl 2):S50-S55
12. Rechtschaffen A, Kales A 1968 A manual of standardized terminology, techniques and scoring system for sleep stages of human subjects. National Institute of Mental Health publication 204. Washington, DC: U.S. Government Printing Office
13. Vgontzas AN, Tan TL, Bixler EO, Martin LF, Shubert D, Kales A 1994 Sleep apnea and sleep disruption in obese patients. Arch Intern Med 154:1705-1711
14. Dinges DF, Weaver TE 2003 Effects of modafinil on sustained attention performance and quality of life in OSA patients with residual sleepiness while being treated with nCPAP. Sleep Med 4:393-402
15. Vgontzas AN, Zoumakis E, Bixler EO, Lin HM, Follett H, Kales A, Chrousos GP 2004 Adverse effects of modest sleep restriction on sleepiness, performance, and inflammatory cytokines. J Clin Endocrinol Metab 89:2119-2126
16. Gold PW, Loriaux DL, Roy A, Kling MA, Calabrese JR, Kellner CH, Nieman LK, Post RM, Pickar D, Gallucci W, Avgerinos P, Paul S, Oldfield EH, Cutler Jr GB, Chrousos GP 1986 Responses to corticotropin-releasing hormone in the hypercortisolism of depression and Cushing's disease. N Engl J Med 314:1329-1335
17. Yanovski JA, Cutler GB, Chrousos GP, Nieman LK 1993 Corticotropin-releasing hormone stimulation following low-dose dexamethasone administration: a new test to distinguish Cushings syndrome from pseudo-Cushings states. JAMA 269:2232-2238
18. Little RC, Milliken GA, Stroup WW, Wolfinger RD 2002 Heterogeneous variance models. In: Little RC, Milliken GA, Stroup WW, Wolfinger RD, eds. SAS system for mixed models. Chap 8. Cary, NC: SAS Institute; 267-302
19. Bjorntorp P 1993 Visceral obesity: "a civilization syndrome." Obes Res 1:206-222
20. Rosmond R, Dallman MF, Bjorntorp P 1998 Stress-related cortisol secretion in men: relationships with abdominal obesity and endocrine, metabolic and hemodynamic abnormalities. J Clin Endocrinol Metab 83:1853-1859
21. Pasquali R, Cantobelli S, Casimirri F, Capelli M, Bortoluzzi L, Flamia R, Labate AM, Barbara L 1993 The hypothalamic-pituitary-adrenal axis in obese women with different patterns of body fat distribution. J Clin Endocrinol Metab 77:341-346
22. Marin P, Darin N, Anemiya T, Andersson B, Jern S, Bjorntorp P 1992 Cortisol secretion in relation to body fat distribution in obese premenopausal women. Metabolism 41:882-886
23. Yanovski JA, Zelitch Yanovski S, Gold PW, Chrousos GP 1997 Differences in corticotropin-releasing hormone-stimulated adrenocorticotropin and cortisol before and after weight loss. J Clin Endocrinol Metab 82:1874-1878
24. Jessop DS, Dallman MF, Fleming D, Lightman SL 2001 Resistance to glucocorticoid feedback in obesity. J Clin Endocrinol Metab 86:4109-4114
25. Salehi M, Ferenczi A, Zumoff B 2005 Obesity and cortisol status. Horm Metab Res 37:193-197
26. Vicennati V, Pasquali R 2000 Abnormalities of the hypothalamic-pituitary-adrenal axis in nondepressed women with abdominal obesity and relations with insulin resistance: evidence for a central and a peripheral alteration. J Clin Endocrinol Metab 85:4093-4098
27. Vgontzas AN, Bixler EO, Tan TL, Kantner D, Martin LF, Kales A 1998 Obesity without sleep apnea is associated with daytime sleepiness. Arch Intern Med 158:1333-1337
28. Bixler EO, Vgontzas AN, Lin HM, Calhoun SL, Vela-Bueno A, Kales A 2005 Excessive daytime sleepiness in a general population sample: the role of sleep apnea, age, obesity, diabetes, and depression. J Clin Endocrinol Metab 90:4510-4515
29. Resta O, Foschino Barbaro MP, Bonfitto P, Giliberti T, Depalo A, Pannacciulli N, De Pergola G 2003 Low sleep quality and daytime sleepiness in obese patients without obstructive sleep apnoea syndrome. J Intern Med 253:536-543
30. Vgontzas AN, Bixler EO, Lin HM, Prolo P, Mastorakos G, Vela-Bueno A, Kales A, Chrousos GP 2001 Chronic insomnia is associated with nyctohemeral activation of the hypothalamic-pituitary-adrenal axis: clinical implications. J Clin Endocrinol Metab 86:3787-3794
31. Vgontzas AN, Bixler EO, Chrousos GP 2006 Obesity-related sleepiness and fatigue: the role of the stress system and cytokines. Ann NY Acad Sci 1083:329-344
32. Pasquali R, Gagliardi L, Vicennati V, Gambineri A, Colitta D, Ceroni L, Casimirri F 1999 ACTH and cortisol response to combined corticotropin releasing hormone-arginine vasopressin stimulation in obese males and its relationship to body weight, fat distribution and parameters of the metabolic syndrome. Int J Obes 23:419-424
33. Lanfranco F, Gianotti L, Pivetti S, Navone F, Rossetto R, Tassone F, Gai V, Ghigo E, Maccario M 2004 Obese patients with obstructive sleep apnoea syndrome show a peculiar alteration of the corticotroph but not of the thyrotroph and lactotroph function. Clin Endocrinol (Oxf) 60:41-48
34. Chrousos GP, Charmandari E, Kino T 2004 Glucocorticoid action networks - an introduction to systems biology. J Clin Endocrinol Metab 89:563-564 (Editorial)
35. Charmandari E, Kino T, Chrousos GP 2004 Glucocorticoids and their actions. An introduction. Ann NY Acad Sci 1024:1-8
36. Yanovski JA, Miller KD, Kino T, Friedman TC, Chrousos GP, Tsigos C, Falloon J 1999 Endocrine and metabolic evaluation of human immunodeficiency virus-infected patients with evidence of protease inhibitor-associated lipodystrophy. J Clin Endocrinol Metab 84:1925-1931
37. Cooper BG, White JE, Ashworth LA, Alberti KG, Gibson GJ 1995 Hormonal and metabolic profiles in subjects with obstructive sleep apnea syndrome and the acute effects of nasal continuous positive airway pressure (CPAP) treatment. Sleep 18:172-179
38. Pepperell JC, Ramdassingh-Dow S, Crosthwaite N, Mullins R, Jenkinson C, Stradling JR, Davies RJ 2002 Ambulatory blood pressure after therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomized parallel trial. Lancet 359:204-210
39. White DP 2006 The pathogenesis of obstructive sleep apnea. Advances in the past 100 years. Am J Respir Cell Mol Biol 34:1-6
40. Mann K, Roschke J, Benkert O, Aldenhoff J, Nink M, Beyer J, Lehnert H 1995 Effects of corticotropin-releasing hormone on respiratory parameters during sleep in normal men. Exp Clin Endocrinol Diabetes 103:233-240
41. Inder WJ, Hellemans J, Swanney MP, Prickette TC, Donald RA 1998 Prolonged exercise increases peripheral plasma ACTH, CRH, and AVP in male athletes. J Appl Physiol 85:835-841
42. Peppard PE, Young T 2004 Exercise and sleep-disordered breathing: an association independent of body habitus. Sleep 27:480-484
43. Vgontzas AN, Bixler EO, Lin HM, Prolo P, Trakada G, Chrousos GP 2005 IL-6 and its circadian secretion in humans. Neuroimmunomodulation 12:131-140